SCHEMBL10425549

SCHEMBL10425549

CS(=O)(=O)NC(=N)N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7976035 0.79 CA2 (0.33)
SCHEMBL193624 0.75 KDM4E (0.35)
SCHEMBL13560816 0.75
Guanidine SCHEMBL5503970 0.74 KDM4E (0.53)
Guanidine SCHEMBL2136925 0.74
Guanidine SCHEMBL19458437 0.74 KDM4E (0.53)
SCHEMBL14583610 0.73
SCHEMBL2565947 0.73
Biguanide SCHEMBL9665553 0.73 KDM4E (0.46)
SCHEMBL19458436 0.73 KDM4E (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109111376-A A kind of 2,5- double deoxidation strepto- amine derivative and its application 四川医立特生物医药有限公司 2019-01-01 CN disclosed
CN-104777301-B Zanamivir phosphonate congeners with anti-influenza activity and determination of oseltamivir susceptibility of influenza viruses 中央研究院 2018-04-20 CN disclosed
EP-2776471-A1 STABLE PEPTIDE-BASED FURIN INHIBITORS Socpra Sciences Santé Et Humaines S.E.C. (CA) 2014-09-17 EP disclosed
EP-2751141-A1 STABLE PEPTIDE-BASED PACE4 INHIBITORS Socpra Sciences Santé Et Humaines S.E.C. (CA) 2014-07-09 EP disclosed
WO-2013029182-A1 STABLE PEPTIDE-BASED FURIN INHIBITORS SOCPRA SCIENCES SANTÉ ET HUMAINES S.E.C. (CA) 2013-03-07 WO disclosed
WO-2013029180-A1 STABLE PEPTIDE-BASED PACE4 INHIBITORS SOCPRA SCIENCES SANTÉ ET HUMAINES S.E.C. (CA) 2013-03-07 WO disclosed
US-8357673-B2 4-arylazo-3,5-diamino-pyrazole compounds and use thereof UNIVERZITA PALACKEHO V OLOMOUCI (CZ) 2013-01-22 US disclosed
US-8034932-B2 Hydroxy-3-methylglutaryl/3-/ coenzyme A reductase inhibitor; anticholesterol agents;dyslipidemia; chemical intermediate for rosuvastatin ASTRAZENECA UK LIMITED (GB) 2011-10-11 US disclosed
EP-2361906-A1 Process for preparing rosuvastatin AstraZeneca UK Limited (GB) 2011-08-31 EP disclosed
US-20100144698-A1 SUBSTITUTED AZETIDINONES DAIAMED (US) 2010-06-10 US disclosed
US-4904792-A N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds ELI LILLY AND COMPANY (US) 1990-02-27 US disclosed
US-4760075-A Miticides ELI LILLY AND COMPANY (US) 1988-07-26 US disclosed
EP-0091220-B1 THIAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ELI LILLY AND COMPANY (US) 1987-05-13 EP disclosed
EP-0049618-B1 IMPROVEMENTS IN OR RELATING TO 2,4-DISUBSTITUTED THIAZOLE DERIVATIVES ELI LILLY AND COMPANY (US) 1985-08-14 EP disclosed
US-4474794-A N-Thiazolylmethylthioalkyl-N1 -alkenyl (or alkynyl)guanidines and related compounds ELI LILLY AND COMPANY (US) 1984-10-02 US disclosed
EP-0002930-B1 AMINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM GLAXO GROUP LIMITED (GB) 1983-12-14 EP disclosed
EP-0091220-A2 Thiazole derivatives, process for their preparation and pharmaceutical compositions containing them ELI LILLY AND COMPANY (US) 1983-10-12 EP disclosed
US-4382090-A N-Thiazolylmethylthioalkyl-N'alkylamidines and related compounds ELI LILLY AND COMPANY (US) 1983-05-03 US disclosed
US-4375547-A ANTIHISTAMINES, 'I RECEPTOR ANTAGONISTS, ANTISECRETORY AGENTS ELI LILLY AND COMPANY (US) 1983-03-01 US disclosed
EP-0049618-A1 Improvements in or relating to 2,4-disubstituted thiazole derivatives ELI LILLY AND COMPANY (US) 1982-04-14 EP disclosed